Compound information
- Natural Products
- ZC405678
- Molecular Formula
- C16H22N2O5
- Molecular Weight
- 322.152871804 g/mol
- Structure
-
- IUPAC Name
- (2S)-6-acetamido-2-(benzyloxycarbonylamino)hexanoic acid
- InChI
- InChI=1S/C16H22N2O5/c1-12(19)17-10-6-5-9-14(15(20)21)18-16(22)23-11-13-7-3-2-4-8-13/h2-4,7-8,14H,5-6,9-11H2,1H3,(H,17,19)(H,18,22)(H,20,21)/t14-/m0/s1
- InChI Key
- NLEKRIPRBRHEPC-AWEZNQCLSA-N
- SMILES
- CC(=O)NCCCC[C@H](NC(=O)OCc1ccccc1)C(=O)O
- Source
- ZINC000002586051
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 23 | Ring Count | 1 |
Heteroatom Count | 7 | Rotatable Bond Count | 9 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 3 |
Topological Polar Surface Area | 104.73 Å2 | LogP | 1.062 |
LogS | -2.693 | LogD | 0.119 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.0 | Pgp substrate | 0.012 |
HIA | 0.0 | F20 % | 0.049 |
F30 % | 0.001 | Caco-2 | -6.06 |
MDCK | -5.61 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.987 | PPB | 70.082 |
VD | 0.421 | Fu | 0.244 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.014 | CYP1A2 substrate | 0.657 |
CYP2A6 substrate | 0.456 | CYP2B6 substrate | 0.498 |
CYP2C19 inhibitor | 0.124 | CYP2C19 substrate | 0.776 |
CYP2C8 substrate | 0.724 | CYP2C9 inhibitor | 0.038 |
CYP2C9 substrate | 0.963 | CYP2D6 inhibitor | 0.051 |
CYP2D6 substrate | 0.549 | CYP2E1 substrate | 0.223 |
CYP3A4 inhibitor | 0.02 | CYP3A4 substrate | 0.634 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.713 | CL | 2.208 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.012 | Hepatotoxicity | 0.065 |
Mutagenicity | 0.017 | Rat Oral Acute Toxicity | 0.017 |
FDAMDD | 0.021 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.002 | Eye Corrosion | 0.002 |
Eye Irritation | 0.016 | Respiratory Toxicity | 0.002 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | -0.244 | IGC50 | 2.097 |
LC50FM | 3.38 | LC50DM | 4.457 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.295 | NR-AR-LBD | 0.312 |
NR-AhR | 0.003 | NR-Aromatase | 0.029 |
NR-ER | 0.312 | NR-ER-LBD | 0.347 |
NR-PPAR-gamma | 0.482 | SR-ARE | 0.051 |
SR-ATAD5 | 0.318 | SR-HSE | 0.078 |
SR-MMP | 0.009 | SR-p53 | 0.018 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.